Annual Interest Expense
$12.62 M
+$2.42 M+23.79%
31 December 2023
Summary:
TG Therapeutics annual interest expense is currently $12.62 million, with the most recent change of +$2.42 million (+23.79%) on 31 December 2023. During the last 3 years, it has risen by +$6.29 million (+99.32%). TGTX annual interest expense is now at all-time high.TGTX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$10.83 M
+$6.86 M+172.37%
30 September 2024
Summary:
TG Therapeutics quarterly interest expense is currently $10.83 million, with the most recent change of +$6.86 million (+172.37%) on 30 September 2024. Over the past year, it has increased by +$7.12 million (+191.73%). TGTX quarterly interest expense is now at all-time high.TGTX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$19.53 M
+$7.12 M+57.37%
30 September 2024
Summary:
TG Therapeutics TTM interest expense is currently $19.53 million, with the most recent change of +$7.12 million (+57.37%) on 30 September 2024. Over the past year, it has increased by +$6.48 million (+49.69%). TGTX TTM interest expense is now at all-time high.TGTX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TGTX Interest Expense Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +23.8% | +191.7% | +49.7% |
3 y3 years | +99.3% | +943.5% | +233.8% |
5 y5 years | +1338.4% | +604.8% | +441.2% |
TGTX Interest Expense High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +123.8% | at high | +943.5% | at high | +246.4% |
5 y | 5 years | at high | +1338.4% | at high | +943.5% | at high | +441.2% |
alltime | all time | at high | >+9999.0% | at high | at high | >+9999.0% |
TG Therapeutics Interest Expense History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $10.83 M(+172.4%) | $19.53 M(+57.4%) |
June 2024 | - | $3.98 M(+73.8%) | $12.41 M(+2.9%) |
Mar 2024 | - | $2.29 M(-5.9%) | $12.06 M(-4.4%) |
Dec 2023 | $12.62 M(+23.8%) | $2.43 M(-34.5%) | $12.62 M(-3.3%) |
Sept 2023 | - | $3.71 M(+2.4%) | $13.05 M(+18.8%) |
June 2023 | - | $3.63 M(+27.5%) | $10.98 M(+5.9%) |
Mar 2023 | - | $2.84 M(-0.6%) | $10.37 M(+1.8%) |
Dec 2022 | $10.19 M(+80.8%) | $2.86 M(+73.7%) | $10.19 M(+21.2%) |
Sept 2022 | - | $1.65 M(-45.4%) | $8.41 M(+7.8%) |
June 2022 | - | $3.02 M(+13.3%) | $7.80 M(+21.8%) |
Mar 2022 | - | $2.66 M(+146.9%) | $6.40 M(+13.6%) |
Dec 2021 | $5.64 M(-10.9%) | $1.08 M(+3.9%) | $5.64 M(-3.6%) |
Sept 2021 | - | $1.04 M(-36.0%) | $5.85 M(-8.9%) |
June 2021 | - | $1.62 M(-14.5%) | $6.42 M(-8.6%) |
Mar 2021 | - | $1.90 M(+47.0%) | $7.03 M(+11.0%) |
Dec 2020 | $6.33 M(+19.7%) | $1.29 M(-19.8%) | $6.33 M(-8.8%) |
Sept 2020 | - | $1.61 M(-27.7%) | $6.94 M(+1.1%) |
June 2020 | - | $2.23 M(+85.5%) | $6.87 M(+20.1%) |
Mar 2020 | - | $1.20 M(-36.8%) | $5.71 M(+8.1%) |
Dec 2019 | $5.29 M(+502.9%) | $1.90 M(+23.6%) | $5.29 M(+46.5%) |
Sept 2019 | - | $1.54 M(+42.7%) | $3.61 M(+57.4%) |
June 2019 | - | $1.08 M(+39.1%) | $2.29 M(+59.4%) |
Mar 2019 | - | $774.00 K(+251.8%) | $1.44 M(+116.6%) |
Dec 2018 | $877.00 K(+3.8%) | $220.00 K(-0.5%) | $664.00 K(+49.5%) |
Sept 2018 | - | $221.00 K(-0.9%) | $444.00 K(+99.1%) |
June 2018 | - | $223.00 K(-9.5%) | $223.00 K(-69.5%) |
Dec 2017 | $845.00 K | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2015 | - | $246.50 K(0.0%) | $730.70 K(+1.6%) |
June 2015 | - | $246.50 K(+3.7%) | $719.00 K(+1.7%) |
Mar 2015 | - | $237.70 K(+1.2%) | $707.30 K(-24.5%) |
Sept 2014 | - | $234.80 K(0.0%) | $936.80 K(-0.6%) |
June 2014 | - | $234.80 K(+3.8%) | $942.50 K(-0.5%) |
Mar 2014 | - | $226.30 K(-6.1%) | $947.70 K(-0.5%) |
Dec 2013 | $952.90 K(+5.2%) | $240.90 K(+0.2%) | $952.90 K(+1.3%) |
Sept 2013 | - | $240.50 K(+0.2%) | $940.90 K(+1.3%) |
June 2013 | - | $240.00 K(+3.7%) | $929.00 K(+1.3%) |
Mar 2013 | - | $231.50 K(+1.1%) | $917.10 K(+1.3%) |
Dec 2012 | $905.70 K(>+9900.0%) | $228.90 K(+0.1%) | $905.70 K(+32.4%) |
Sept 2012 | - | $228.60 K(+0.2%) | $683.90 K(+50.2%) |
June 2012 | - | $228.10 K(+3.6%) | $455.30 K(+100.4%) |
Mar 2012 | - | $220.10 K(+3000.0%) | $227.20 K(-3.0%) |
Dec 2011 | $7100.00(-99.4%) | $7100.00(>+9900.0%) | $234.30 K(-58.2%) |
Sept 2011 | - | $0.00(0.0%) | $560.70 K(-38.4%) |
June 2011 | - | $0.00(-100.0%) | $910.30 K(-27.8%) |
Mar 2011 | - | $227.20 K(-31.9%) | $1.26 M(-0.8%) |
Dec 2010 | $1.27 M(+131.8%) | $333.50 K(-4.6%) | $1.27 M(+16.7%) |
Sept 2010 | - | $349.60 K(-0.5%) | $1.09 M(+24.3%) |
June 2010 | - | $351.20 K(+48.3%) | $876.40 K(+32.8%) |
Mar 2010 | - | $236.80 K(+56.1%) | $659.70 K(+20.3%) |
Dec 2009 | $548.40 K(+746.3%) | $151.70 K(+11.0%) | $548.40 K(+38.2%) |
Sept 2009 | - | $136.70 K(+1.6%) | $396.70 K(+52.6%) |
June 2009 | - | $134.50 K(+7.2%) | $260.00 K(+107.2%) |
Mar 2009 | - | $125.50 K | $125.50 K |
Dec 2008 | $64.80 K | - | - |
FAQ
- What is TG Therapeutics annual interest expense?
- What is the all time high annual interest expense for TG Therapeutics?
- What is TG Therapeutics annual interest expense year-on-year change?
- What is TG Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for TG Therapeutics?
- What is TG Therapeutics quarterly interest expense year-on-year change?
- What is TG Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for TG Therapeutics?
- What is TG Therapeutics TTM interest expense year-on-year change?
What is TG Therapeutics annual interest expense?
The current annual interest expense of TGTX is $12.62 M
What is the all time high annual interest expense for TG Therapeutics?
TG Therapeutics all-time high annual interest expense is $12.62 M
What is TG Therapeutics annual interest expense year-on-year change?
Over the past year, TGTX annual interest expense has changed by +$2.42 M (+23.79%)
What is TG Therapeutics quarterly interest expense?
The current quarterly interest expense of TGTX is $10.83 M
What is the all time high quarterly interest expense for TG Therapeutics?
TG Therapeutics all-time high quarterly interest expense is $10.83 M
What is TG Therapeutics quarterly interest expense year-on-year change?
Over the past year, TGTX quarterly interest expense has changed by +$7.12 M (+191.73%)
What is TG Therapeutics TTM interest expense?
The current TTM interest expense of TGTX is $19.53 M
What is the all time high TTM interest expense for TG Therapeutics?
TG Therapeutics all-time high TTM interest expense is $19.53 M
What is TG Therapeutics TTM interest expense year-on-year change?
Over the past year, TGTX TTM interest expense has changed by +$6.48 M (+49.69%)